Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) Q1 2024 Earnings Conference Call May 8, 2024 4:30 PM ET
Company Participants
Mihael Polymeropoulos - President, Chairman and CEO
Kevin Moran - CFO
Tim Williams - Senior Vice President and General Counsel
Conference Call Participants
Operator
Thank you for standing by. My name is Hermine, and I will be your conference operator today. At this time, I would like to welcome everyone to Q1 2024 Vanda Pharmaceuticals, Inc. Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions].
I would now like to turn the call over to Vanda's Chief Financial Officer, Kevin Moran. Please go ahead.
Kevin Moran
Thank you, Hermine. Good afternoon, and thank you for joining us to discuss Vanda Pharmaceuticals' first quarter 2024 performance. Our first quarter 2024 results were released this afternoon and are available on the SEC's EDGAR System and on our website, www.vandapharma.com. In addition, we are providing live and archived versions of this conference call on our website.
Joining me on today's call is Dr. Mihael Polymeropoulos, our President, Chief Executive Officer and Chairman of the Board; and Tim Williams, our General Counsel. Following my introductory remarks, Mihael will update you on our ongoing activities. I will then comment on our financial results before we open the lines for your questions.
Before we proceed, I would like to remind everyone that various statements that we make on this call will be forward-looking statements within the meaning of federal securities laws. Our forward-looking statements are based upon current expectations and assumptions that involve risks, changes in circumstances and uncertainties. These risks are described in the cautionary note regarding forward-looking statements, risk factors and Management's Discussion and Analysis of Financial Condition and Results of Operations sections of
- Read more current VNDA analysis and news
- View all earnings call transcripts